Form 4 for MGRX MANGOCEUTICALS, INC.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-03 · accession 0001493152-23-035677 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-03 | MGRX | JOHNSTON EUGENE M | CFO | A - Grant | $0.00 | +50.0K | 200.0K | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-03 | A | A | 50,000 | $0.00 | 200,000 | D | — | — | (F1) Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |